MEDIPOSTCO.,LTD.
Develops stem cell therapeutics and regenerative medicine for incurable diseases.
078160 | KO
Overview
Corporate Details
- ISIN(s):
- KR7078160009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 대왕판교로 644번길21 -, 성남시
- Website:
- https://en.medi-post.co.kr/
- Sector:
- Manufacturing
Description
MEDIPOST is a biotechnology company specializing in the research, development, and commercialization of stem cell therapeutics and regenerative medicine. The company focuses on addressing unmet medical needs for incurable diseases through its proprietary stem cell platform technology. Its core operations include a cord blood banking service and the development of allogeneic stem cell therapies. Key commercialized products include CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. The company's clinical pipeline features next-generation injectable treatments for conditions such as osteoarthritis and diabetic nephropathy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-19 00:00 |
사업보고서 (2020.12)
|
Korean | 1.9 MB | ||
| 2021-03-15 00:00 |
투자판단관련주요경영사항(무릎골관절염치료제 카티스템 말레이시아 품목허가(BLA) 신청)
|
Korean | 7.4 KB | ||
| 2021-03-08 00:00 |
주주총회소집공고
|
Korean | 1.1 MB | ||
| 2021-03-08 00:00 |
의결권대리행사권유참고서류
|
Korean | 1.1 MB | ||
| 2021-03-03 00:00 |
주주총회소집결의
|
Korean | 7.8 KB | ||
| 2021-03-03 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.8 KB | ||
| 2021-02-15 00:00 |
투자판단관련주요경영사항(무릎골관절염 환자를 대상으로 EVA-001(카티스템)의 일본임상 3상 임상시험계획(CTN) 승인)
|
Korean | 9.7 KB | ||
| 2021-02-15 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.1 KB | ||
| 2021-02-09 00:00 |
기타경영사항(특허권취득)(자율공시)(피부세포 활성화용 조성물 및 이의 용도)
|
Korean | 4.7 KB | ||
| 2021-02-09 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 80.1 KB | ||
| 2021-02-05 00:00 |
[기재정정]전환청구권행사
|
Korean | 13.9 KB | ||
| 2021-02-03 00:00 |
전환청구권행사
|
Korean | 10.7 KB | ||
| 2021-02-02 00:00 |
투자판단관련주요경영사항(무릎골관절염 환자를 대상으로 EVA-001(카티스템) 일본임상 3상 임상시험계획승인(CTN) 신청)
|
Korean | 9.5 KB | ||
| 2020-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2020-11-16 00:00 |
분기보고서 (2020.09)
|
Korean | 1.4 MB |
Automate Your Workflow. Get a real-time feed of all MEDIPOSTCO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MEDIPOSTCO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MEDIPOSTCO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
